The complex signaling cascades of RAS, including the most pivotal RAS–RAF–MEK–ERK pathway (MAPK pathway), have been gradually identified, which has justified the approach to target altered RAS as a cancer treatment as well (5). This evidence concerns the gene RAF1 and cancer.